Sarina Piha-Paul

33PUBLICATIONS
242CO-AUTHORS
Molecular targetsPredictive and prognostic markersNeurology and neuromuscular diseasesCancer therapy (excl. chemotherapy and radiation therapy)Nutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Aug 11, 2026
Phase I safety, efficacy, and biomarker response evaluations of three oral PD-L1 inhibitors: INCB086550, INCB099280, and INCB099318.

|Jul 23, 2026
Multikinase Inhibition with Tinengotinib in Advanced Solid Tumors: Results from a Multicenter Phase Ib/II Trial.

|Jun 24, 2026
Artificial intelligence-guided analysis of the tumor microenvironment predicts response to pembrolizumab in rare tumors.

|Apr 20, 2026
First-in-Human, Phase I Study of Sigvotatug Vedotin, an Integrin Beta-6-Directed Antibody-Drug Conjugate: Results From Dose Expansion in Advanced Non-Small Cell Lung Cancer.

|Mar 26, 2026
Comprehensive Genomic and Transcriptomic Analysis to Guide Therapy for Patients with Metastatic Solid Tumors.

Burak Uzunparmak, Fei Su, Amber Johnson

|Dec 05, 2025
Presenting Features and Causes of Diagnostic Delays: A Report From the NUT Carcinoma Registry.

Sara A Walton, Justin J Kim, Francesco Paoloni

Pageof 6

Frequent Collaborators

11 joint publications

Aung Naing

9 joint publications

David S Hong

9 joint publications

Funda Meric-Bernstam

7 joint publications

Jordi Rodon Ahnert